Wellington Shields & Co. LLC Sells 1,700 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Wellington Shields & Co. LLC cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 28.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,200 shares of the pharmacy operator’s stock after selling 1,700 shares during the quarter. Wellington Shields & Co. LLC’s holdings in Walgreens Boots Alliance were worth $51,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Iron Horse Wealth Management LLC lifted its stake in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 1,300 shares in the last quarter. Pineridge Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at $26,000. Blue Trust Inc. lifted its stake in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 1,081 shares in the last quarter. Quest Partners LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at $30,000. Finally, Continuum Advisory LLC lifted its stake in shares of Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,020 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on WBA. Royal Bank of Canada dropped their price objective on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a research note on Tuesday, July 2nd. Barclays lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a report on Tuesday, July 23rd. TD Cowen lowered their target price on shares of Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating for the company in a report on Monday, July 1st. Truist Financial lowered their target price on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday, June 28th. Finally, Bank of America lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $15.19.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $8.74 on Thursday. Walgreens Boots Alliance, Inc. has a 52-week low of $8.46 and a 52-week high of $27.05. The company has a 50-day simple moving average of $10.60 and a 200 day simple moving average of $15.32. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The company has a market capitalization of $7.55 billion, a PE ratio of -1.30, a price-to-earnings-growth ratio of 0.93 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). The business had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. Walgreens Boots Alliance’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.00 EPS. On average, research analysts predict that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st will be paid a $0.25 dividend. The ex-dividend date is Wednesday, August 21st. This represents a $1.00 annualized dividend and a dividend yield of 11.44%. Walgreens Boots Alliance’s payout ratio is -14.84%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.